Chondroitin Sulfate

FDA proposes delayed track and trace rollout; GSK forays into artificial intelligence-aided drug research

This week, Phispers brings you news on an apex court ruling in Canada that overhauls its patent law

Compliance Wrap: Heparin quality concerns re-emerge in China, more trouble at Sun Pharma & Wockhardt

PharmaCompass looks at recent compliance concerns highlighted by the US FDA at drug manufacturers li

If deleting electronic records is okay, then it must be okay to rip out pages from lab notebooks

This week, Speak Pharma interviews Mark S. Paxton, the Chief Executive Officer of Rx-360, a non-prof

Phispers: Another Heparin scandal in China, GSK may have a new CEO, Female libido pill problems

Pharmaceutical Whispers (Phispers) this week cover another major heparin scandal emanating from

Counterfeit drugs: Toyota’s highest ranking female employee arrested; it’s time to understand!

Yesterday, on July 1, 2015, the Drug Supply Chain Security Act (or Drug Quality and Security Act) b